Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 2 papers. Top paper: “A High-Throughput Screening Platform Identifies FDA-Approved Drugs That Inhibit SREBP Pathway Activation”.
Casie S. Kubota, Evan Carlyle, Takashi Tsukamoto, Peter J. Espenshade, Chiaki T. Ishida
Evan Carlyle, Viviana Smart, Apurv Rege, Charles J. Bieberich, Katherine L. Seley‐Radtke +1 more